Skip to main content
Clinical Trials/DRKS00023519
DRKS00023519
Completed
Not Applicable

How do psychological factors interact with the oncological outcomes of women with triple-negative breast cancer? - PSY-ONC TNBC

Carl von Ossietzky Universität Oldenburg0 sites29 target enrollmentApril 14, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C50
Sponsor
Carl von Ossietzky Universität Oldenburg
Enrollment
29
Status
Completed
Last Updated
last year

Overview

Brief Summary

Biological and physiological changes in response to stress are crucial to adapting to environmental constraints. Typical stress responses activate the sympathetic nervous system and the hypothalamic-pituitary-adrenal cortical axis, which aim to maintain homeostasis in response to demands and influence various biological responses at neuroendocrine, cellular, and immune levels. In particular, there is compelling evidence showing the devastating effects of high-stress levels on immune responses and brain functionality. In that sense, data suggest that a sustained stress-physiological response predicts decreases in immunity and leads to allostatic load, the wear and tear of biological systems. Similarly, in cancer research, chronic stress levels have been reported to impair the body-surveillance systems and be related to cancer incidence, progression, and mortality. Despite the evidence demonstrating the associations between stress and cancer, there are limited data on whether lifetime stress exposure relates to clinical indicators of cancer aggressiveness. Considering the evidence showing the adverse effects of prolonged stress exposure on cancer disease, this thesis aimed to explore the relationship between lifetime stress exposure and the clinical characteristics of tumor-aggressiveness in a cohort of patients affected with triple-negative breast cancer (TNBC). Likewise, as research has shown that coping responses moderate the stress-physiological response, we aimed to investigate the role of coping responses in moderating the association between tumor aggressiveness and lifetime stress exposure. According to the scientific literature, high-stress levels would increase physiological arousal and allostatic load favoring a debilitated immune system. Thus, we hypothesized finding positive associations between lifetime stress exposure and tumor-aggressiveness. In the same line, we suspected that adaptative coping styles would be negatively related to tumor-aggressiveness. The participants of this study were 29 women diagnosed with TNBC who were treated in the University Hospital for Gynecology Pius-Hospital (Oldenburg, Germany). Correlation and moderation regression analyses with the use of composite scores were conducted. Overall, we could not demonstrate significant associations between lifetime stress exposure and coping responses on the clinical indicators of tumor aggressiveness in this cohort of patients. Possible explanations for these results are discussed, and suggestions for future research are provided. This study was the first to investigate the effect of lifetime stress exposure and coping response on the aggressive tumor characteristics of TNBC. We provided a deep theoretical framework to understand the interplay between biological and psychological aspects of cancer disease, and we hope that our recommendations may serve as a base for upcoming studies.

Registry
who.int
Start Date
April 14, 2023
End Date
November 7, 2022
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Female sex, confirmed diagnosis of TNBC, the ability to speak and understand German, andthe ability to give informed consent.

Exclusion Criteria

  • An unconfirmed TNBC diagnosis, woman whose medical records are lacking clinical and/or pathological variables of interest, a current or previous mood disorder, psychosis, anxiety disorder, psychosis, anxiety disorder, or substance abuse disorder according to the DSM V, Diagnostic and Statistical Manual of Mental Disorders, and/or current use of psychotropic agents or psychiatric drugs.

Outcomes

Primary Outcomes

Not specified

Similar Trials